
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Practical AI Solutions for Text-to-Audio Synthesis The demand for AI-generated content is rising across industries, especially in multimedia. Advanced generative AI models like ChatGPT, GEMINI, and BARD are being sought…
“`html Effect of Vitamin D and Letrozole on Ovulation in Polycystic Ovary Syndrome Published: BMJ Open, April 29, 2024 Low vitamin D levels are common in women with polycystic ovary…
Study Results: What Worked and What Didn’t The study tested a new tool called the Fatigue Differential Diagnostic Aid (FDDA) to help doctors understand and manage unexplained fatigue in patients.…
Ensuring Accessible Healthcare: How AI and Digital Solutions Improve Patient Availability By Dr. Maxwell Trenton, Head of AI Solutions at MedTech Innovators Ltd. At aidevmd.com, we believe healthcare should be…
KIADEKU Project Overview The KIADEKU project is focused on improving wound care for conditions like incontinence-associated dermatitis (IAD) and pressure ulcers (PU) by using an AI application. This project combines…
Study Overview This study focused on major cardiovascular events (MACE) that can occur after a procedure called percutaneous coronary intervention (PCI). These events are a leading cause of death for…